PDS Plus (Polydioxanon) Nahtmaterial

PDS Plus ist ein langsam resorbierbares Nahtmaterial, das IRGACARE MP, die reinste Form von TRICLOSAN, enthält und somit eine Hemmzone gegen die häufigsten grampositiven und gramnegativen Erreger postoperativer Wundinfektionen bildet. PDS Plus ist dort indiziert, wo mit verzögerter Wundheilung zu rechnen und eine sichere Wundadaption für längere Zeit (bis zu 6 Wochen) erwünscht ist. Indikationsgebiete: Bauchwandverschluss, Faszienverschluss, Darmanastomosen, Bänder- und Sehnenadaption, Handchirurgie. PDS Plus weist nach 42 Tagen noch 60% seiner ursprünglichen Reißfestigkeit auf. Der komplette Reißkraftverlust tritt nach 70 Tagen ein. Das Material verbleibt zwischen 182–238 Tagen im Körper.1*

PDS Plus (Polydioxanon) Nahtmaterial

Verweise

* PDS Plus Antibacterial Suture Contains IRGACARE® ‡ MP (Triclosan), a broad spectrum antibiotic not exceeding 2360 μg/m.1 The PDS Plus Antibacterial Sutures are indicated for use in the general adaptation of soft tissue, including pediatric cradiovascular tissue and ophthalmic surgery (out of contact with the cornea and sclera). These sutures are particularly useful when the combination of resorbable suture material and long-term wound retention (up to 6 weeks) is desirable.1 These sutures should not be adapted for long-term (longer than 6 weeks) adaptation of tissues under loading or in conjunction with prosthetic products, eg. As heart valves or synthetic grafts are used. The PDS Plus Antibacterial Suture should not be used in patients with known allergic reactions to IRGACARE® ‡ MP (Triclosan)
1. Ethicon Inc, PDS Plus Antibacterial (polydioxanone) suture, instructions for use.

PDS Plus (Polydioxanon) Nahtmaterial, Instructions for Use. Ethicon, Inc.
For detailed information, contraindications, warnings, precautions and side effects, please refer to the full instructions for use.

This website is published by the company Johnson & Johnson Medical N.V., Belgium, which is solely responsible for the content. The website is only for EMEA target groups.

This website is for healthcare professionals. If you are a patient, it is important that you discuss information about the benefits and risks of your product with your doctor.

As of: December 15, 2017. The third-party trademarks used herein are the property of their respective owners. There may be data and usage fees. For more information, contact your network operator.